AstraZeneca in cancer viruses deal with Omnis Pharmaceuticals
January 12, 2015 at 02:24 AM EST
LONDON, Jan 12 (Reuters) - AstraZeneca said on Monday its MedImmune biotech unit had struck a deal with unlisted U.S. company Omnis Pharmaceuticals on the development of cancer-fighting oncolytic viruses.
